BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 34750323)

  • 21. Model for end-stage liver disease score and hemodynamic instability as a predictor of poor outcome in early transjugular intrahepatic portosystemic shunt treatment for acute variceal hemorrhage.
    Hermie L; Dhondt E; Vanlangenhove P; Hoste E; Geerts A; Defreyne L
    Eur J Gastroenterol Hepatol; 2018 Dec; 30(12):1441-1446. PubMed ID: 30048333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MELD 3.0 Score for Predicting Survival in Patients with Cirrhosis After Transjugular Intrahepatic Portosystemic Shunt Creation.
    Song J; Wang X; Yan Y; Xiang T; Luo X
    Dig Dis Sci; 2023 Jul; 68(7):3185-3192. PubMed ID: 36715817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MELD or Sodium MELD: A Comparison of the Ability of Two Scoring Systems to Predict Outcomes After Transjugular Intrahepatic Portosystemic Shunt Placement.
    Young S; Rostambeigi N; Golzarian J; Lim N
    AJR Am J Roentgenol; 2020 Jul; 215(1):215-222. PubMed ID: 32432911
    [No Abstract]   [Full Text] [Related]  

  • 24. Predictors of Re-bleeding and Mortality Among Patients with Refractory Variceal Bleeding Undergoing Salvage Transjugular Intrahepatic Portosystemic Shunt (TIPS).
    Maimone S; Saffioti F; Filomia R; Alibrandi A; Isgrò G; Calvaruso V; Xirouchakis E; Guerrini GP; Burroughs AK; Tsochatzis E; Patch D
    Dig Dis Sci; 2019 May; 64(5):1335-1345. PubMed ID: 30560334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early Liver Failure after Transjugular Intrahepatic Portosystemic Shunt in Patients with Cirrhosis with Model for End-Stage Liver Disease Score of 12 or Less: Incidence, Outcome, and Prognostic Factors.
    Luca A; Miraglia R; Maruzzelli L; D'Amico M; Tuzzolino F
    Radiology; 2016 Aug; 280(2):622-9. PubMed ID: 26982564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic capability of different liver disease scoring systems for prediction of early mortality after transjugular intrahepatic portosystemic shunt creation.
    Gaba RC; Couture PM; Bui JT; Knuttinen MG; Walzer NM; Kallwitz ER; Berkes JL; Cotler SJ
    J Vasc Interv Radiol; 2013 Mar; 24(3):411-20, 420.e1-4; quiz 421. PubMed ID: 23312989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Right atrial pressure may impact early survival of patients undergoing transjugular intrahepatic portosystemic shunt creation.
    Parvinian A; Bui JT; Knuttinen MG; Minocha J; Gaba RC
    Ann Hepatol; 2014; 13(4):411-9. PubMed ID: 24927612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of model performance to predict survival after transjugular intrahepatic portosystemic shunt placement.
    Allegretti AS; Frenk NE; Li DK; Seethapathy H; Vela Parada XF; Long J; Endres P; Pratt DS; Chung RT; Ganguli S; Irani Z; Yamada K
    PLoS One; 2019; 14(5):e0217442. PubMed ID: 31120995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A propensity score matching analysis of neutrophil to lymphocyte ratio forecasts the survival of individuals undergoing the transjugular intrahepatic portosystemic shunt.
    Yang W; Tang H; Zhong B; Zhu X; Chen S
    Biotechnol Genet Eng Rev; 2023 Apr; ():1-15. PubMed ID: 37010061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics and outcomes of transjugular intrahepatic portosystemic shunt recipients in the VA Healthcare System.
    Lerrigo R; Beste LA; Leipertz SL; Green PK; Lok AS; Kogut MJ; Ioannou GN
    Eur J Gastroenterol Hepatol; 2016 Jun; 28(6):667-75. PubMed ID: 26886386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage.
    Jalan R; Elton RA; Redhead DN; Finlayson ND; Hayes PC
    J Hepatol; 1995 Aug; 23(2):123-8. PubMed ID: 7499782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MELD-Na as a prognostic indicator of 30- and 90-day mortality in patients with end-stage liver disease after creation of transjugular intrahepatic portosystemic shunt.
    Ahmed R; Santhanam P; Rayyan Y
    Eur J Gastroenterol Hepatol; 2015 Oct; 27(10):1226-7. PubMed ID: 26111072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic hydrothorax does not increase the risk of death after transjugular intrahepatic portosystemic shunt in cirrhosis patients.
    Gou X; Jia W; He C; Yuan X; Niu J; Xu J; Han N; Zhu Y; Wang W; Tie J
    Eur Radiol; 2023 May; 33(5):3407-3415. PubMed ID: 36576548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transjugular intrahepatic portosystemic shunt in cirrhosis: An exhaustive critical update.
    Rajesh S; George T; Philips CA; Ahamed R; Kumbar S; Mohan N; Mohanan M; Augustine P
    World J Gastroenterol; 2020 Oct; 26(37):5561-5596. PubMed ID: 33088154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of Patient Survival with Psoas Muscle Density Following Transjugular Intrahepatic Portosystemic Shunts: A Retrospective Cohort Study.
    Zhang B; Cai W; Gao F; Lin X; Qian T; Gu K; Song B; Chen T
    Med Sci Monit; 2022 Jan; 28():e934057. PubMed ID: 35031594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transjugular intrahepatic portosystemic shunt placement for refractory ascites: a single-centre experience.
    Lodato F; Berzigotti A; Lisotti A; Azzaroli F; Mosconi C; Giampalma E; Renzulli M; Cappelli A; Buonfiglioli F; Calvanese C; Zoli M; Golfieri R; Mazzella G
    Scand J Gastroenterol; 2012 Dec; 47(12):1494-500. PubMed ID: 22958120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incrementally Expandable Transjugular Intrahepatic Portosystemic Shunts: Single-Center Experience.
    Cui J; Smolinski SE; Liu F; Xu D; Dulaimy K; Irani Z
    AJR Am J Roentgenol; 2018 Feb; 210(2):438-446. PubMed ID: 29261352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transjugular intrahepatic portosystemic shunt: where are we?
    Altun R; Yıldırım E; Ocal S; Akbaş E; Harman A; Kormaz M; Selçuk H
    Turk J Gastroenterol; 2014 Jun; 25(3):298-303. PubMed ID: 25141319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic impact of renal impairment and sodium imbalance in patients undergoing transjugular intrahepatic portosystemic shunting for the prevention of variceal rebleeding.
    Schepke M; Roth F; Koch L; Heller J; Rabe C; Brensing KA; Schiedermaier P; Schild HH; Sauerbruch T
    Digestion; 2003; 67(3):146-53. PubMed ID: 12853726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conversion of failed transjugular intrahepatic portosystemic shunt to distal splenorenal shunt in patients with Child A or B cirrhosis.
    Selim N; Fendley MJ; Boyer TD; Galloway JR; Branum GD
    Ann Surg; 1998 Apr; 227(4):600-3. PubMed ID: 9563552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.